ChemoCentryx, Inc. Deferred Tax Assets, Gross
ChemoCentryx, Inc. had Deferred Tax Assets, Gross of $225.30 million as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2022-03-01
- 2021-12-31: Deferred Tax Assets, Gross $225.30M.
- 2020-12-31: Deferred Tax Assets, Gross $191.49M.
- 2019-12-31: Deferred Tax Assets, Gross $143.12M.
- 2018-12-31: Deferred Tax Assets, Gross $102.90M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2021-12-31 | $225.30M 10-K · filed 2022-03-01 |
| 2020-12-31 | $191.49M 10-K · filed 2022-03-01 |
| 2019-12-31 | $143.12M 10-K · filed 2021-03-01 |
| 2018-12-31 | $102.90M 10-K · filed 2020-03-10 |
| 2017-12-31 | $83.74M 10-K · filed 2019-03-11 |
| 2016-12-31 | $123.75M 10-K · filed 2018-03-12 |
| 2015-12-31 | $108.54M 10-K · filed 2017-03-14 |
| 2014-12-31 | $89.28M 10-K · filed 2016-03-14 |
| 2013-12-31 | $70.96M 10-K · filed 2015-03-13 |
| 2012-12-31 | $54.30M 10-K · filed 2014-03-14 |
| 2011-12-31 | $38.55M 10-K · filed 2013-03-14 |